Clin2
NCT07381556Likely a fitRecruiting

Comparing cyclosporine and methotrexate for kids with alopecia areata

Alopecia Areata(AA)Alopecia Areata (AA)Alopecia Totalis/UniversalisAlopecia Universalis (AU)Alopecia Totalis (AT)Alopecia Areata (& Ophiasis)

Treatments studied

Part of Skin clinical trials.

This study compares two medicines, cyclosporine and methotrexate, to see which works better for children with alopecia areata (a condition causing hair loss). It aims to help doctors choose the best treatment for each child.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
50 people
Ages
2 years to 17 years
Study type
Interventional

Who can take part

  • Aged 2 to 17 years old
  • Diagnosed with alopecia areata by a skin doctor (dermatologist)
  • Willing to take study medicine and come to clinic visits

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07406204Not yet recruiting· Phase 4
Tofacitinib compared to methotrexate for severe hair loss

This study compares two existing medicines — tofacitinib and methotrexate — to see which one is better at treating severe alopecia areata, a condition that causes patchy or total hair loss. If you have severe hair loss, this trial might help you find an effective treatment.

NCT07049328Recruiting· Phase 1
Study of HCW9302 for Alopecia Areata

This trial tests a new drug, HCW9302, that targets the immune system to help hair regrow in people with alopecia areata (including extensive forms like totalis or universalis). It may be an option for adults who have not responded well to other treatments.

Tampa, Florida
NCT07190534Not yet recruiting
Hydroxychloroquine versus methotrexate for frontal fibrosing alopecia

This study compares two medications, hydroxychloroquine and methotrexate, to see which works better for treating frontal fibrosing alopecia, a condition that causes hair loss at the front of the scalp. You'll be assigned to one of the two treatments, and your progress will be followed during routine care.

Rotterdam, South Holland
NCT07459933Not yet recruiting· Phase 4
Comparing two topical treatments for patchy hair loss

This study tests whether a methotrexate lotion or minoxidil lotion is better at regrowing hair in people with patchy hair loss on the scalp. You will use one of the treatments for a period of time, and the doctors will check your progress.

NCT06239311Recruiting· Phase 3
Methotrexate vs placebo for adults with eczema

This trial tests if methotrexate, a medication that calms the immune system, can help adults with moderate-to-severe eczema that hasn't improved with creams or other treatments. You'll either receive methotrexate or a placebo to see which works better.

Prague, Praha 1
NCT07453238Not yet recruiting· Phase 4
Comparing two creams for patchy hair loss

This study compares two treatments for patchy hair loss on the scalp: a vitamin D-like cream (calcipotriol) and steroid injections (intralesional steroids). It aims to see which is more effective at regrowing hair in adults with less than half of the scalp affected.

Hear when a new Alopecia Areata(AA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.